CROWN is the first large, phase IIIb trial to evaluate the investigational use of LA Cabenuva versus daily oral therapy in ...

A retrospective study reported high recent use of GLP-1 receptor agonists in people living with HIV at a UK centre, with ...

As the population of people with HIV ages, researchers studied cognitive health changes; 46% of study participants were ...

University of British Columbia news release. The HPV vaccine provides strong, long-lasting protection for women living with ...

Women with HIV have almost twice the risk of CVD compared to women without HIV, while men with HIV have a 44% increased risk ...

ECDC released a report assessing the current situation regarding availability and access to prevention, testing, and ...

Mirum Pharmaceuticals press release. Mirum Pharmaceuticals, Inc. announced the primary endpoint was met in the Phase 3 ...

Among women with steatotic liver disease, HIV was associated with 48% greater adjusted odds of clinically significant ...

Researchers and clinicians are turning to new tools amidst an evolution in strategies for reducing cardiovascular risk in ...

HIV-positive people had elevated rates of both infection-related malignancies and cancers not linked to infections.

WHO announced a major expansion of its prequalification programme to include a wider range of life-saving medical devices ...

Study offered a potential explanation for why neurological complications persist despite antiretroviral treatment.